reserpine has been researched along with 6-bromoindirubin-3'-oxime in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Ahn, Y; Cho, H; Jeong, P; Jung, DW; Kim, SW; Kim, WH; Kim, YC; Lee, JM; Seo, S; Shen, H; Williams, DR | 1 |
2 other study(ies) available for reserpine and 6-bromoindirubin-3'-oxime
| Article | Year |
|---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
A novel indirubin derivative that increases somatic cell plasticity and inhibits tumorigenicity.
Topics: Carcinogenesis; Cell Plasticity; Humans; Indoles; Protein Kinase Inhibitors | 2019 |